TIL therapy, or tumor-infiltrating lymphocyte therapy, is a cutting-edge cancer treatment now FDA-approved for metastatic melanoma. Dr. Melhem Solh, a hematologist-oncologist at Northside Hospital’s Blood and Marrow Transplant Program, explains how this innovative approach uses a patient’s own immune cells to attack and destroy cancer.
In this video, Dr. Solh walks through the full treatment process, from identifying eligible patients to resecting a tumor sample and expanding billions of lymphocytes in a lab. Once ready, these immune cells are infused back into the patient after a short course of chemotherapy, with the goal of putting the cancer into remission.
Northside Hospital was one of the first centers in the country approved to offer TIL therapy, and with more than 60 cases reviewed and over a dozen infusions completed, the team has quickly built a strong foundation in this advanced form of immunotherapy.
If you or someone you know is facing metastatic melanoma, this video offers a clear and hopeful look at what’s possible through the latest in cell therapy.
